Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...

Globus Medical Inc. stock grades by Barron's. View GMED fundamental and sentiment analysis powered by MarketGrader.

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

These are also areas where the burden of disease is high and access to medical care can be low. Data from the Australian Bureau of Statistics shows that while life expectancy has been improving ...

Getting life insurance typically requires a medical exam to give your provider a clearer picture of your health status. But there are policies available that don't require an examination ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Truist lowered the firm’s price target on Globus Medical (GMED) to $80 from $82 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology.

Commissions do not affect our editors' opinions or evaluations. Major medical insurance is comprehensive health insurance that covers medical services, hospitalizations, doctor visits ...

On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...